The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review.

IF 4.1 2区医学 Q1 SUBSTANCE ABUSE

Current Addiction Reports Pub Date : 2023-01-01 Epub Date: 2023-04-25 DOI:10.1007/s40429-023-00480-9

Noam Fast, Robin van Kessel, Keith Humphreys, Natalie Frances Ward, Andres Roman-Urrestarazu

{"title":"The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review.","authors":"Noam Fast, Robin van Kessel, Keith Humphreys, Natalie Frances Ward, Andres Roman-Urrestarazu","doi":"10.1007/s40429-023-00480-9","DOIUrl":null,"url":null,"abstract":"Purpose of review: This article aims to review and synthesize the current research evidence regarding the efficacy of telepsychiatry-delivered substance use disorder treatment using a narrative review with a focus on the effects of remote healthcare delivery within the substance abuse treatment space.Recent findings: The COVID-19 pandemic exerted substantial pressures on all levels of society. Social isolation, loss of employment, stress, physical illness, overburdened health services, unmet medical needs, and rapidly changing pandemic restrictions had particularly severe consequences for people with mental health issues and substance use disorders. Since the start of the pandemic, addiction treatment (and medical treatment overall) using remote health platforms has significantly expanded to different platforms and delivery systems. The USA, in particular, reported transformational policy developments to enable the delivery of telehealth during the COVID-19 pandemic. However, systemic barriers such as a widespread lack of internet access and insufficient patient and provider digital skills remain.Summary: Overall, telepsychiatry is a promising approach for the treatment of substance use disorders, but more randomized controlled trials are needed in the future to assess the evidence base of available interventions.","PeriodicalId":52300,"journal":{"name":"Current Addiction Reports","volume":"10 2","pages":"187-197"},"PeriodicalIF":4.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126560/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Addiction Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40429-023-00480-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 5

Abstract

Purpose of review: This article aims to review and synthesize the current research evidence regarding the efficacy of telepsychiatry-delivered substance use disorder treatment using a narrative review with a focus on the effects of remote healthcare delivery within the substance abuse treatment space.

Recent findings: The COVID-19 pandemic exerted substantial pressures on all levels of society. Social isolation, loss of employment, stress, physical illness, overburdened health services, unmet medical needs, and rapidly changing pandemic restrictions had particularly severe consequences for people with mental health issues and substance use disorders. Since the start of the pandemic, addiction treatment (and medical treatment overall) using remote health platforms has significantly expanded to different platforms and delivery systems. The USA, in particular, reported transformational policy developments to enable the delivery of telehealth during the COVID-19 pandemic. However, systemic barriers such as a widespread lack of internet access and insufficient patient and provider digital skills remain.

Summary: Overall, telepsychiatry is a promising approach for the treatment of substance use disorders, but more randomized controlled trials are needed in the future to assess the evidence base of available interventions.

查看原文本刊更多论文

新冠肺炎期间药物使用障碍远程精神病学的演变：叙述性评论。

综述目的：本文旨在通过叙述性综述，回顾和综合当前关于远程精神治疗药物使用障碍疗效的研究证据，重点关注药物滥用治疗空间内远程医疗服务的效果。最近的研究结果：新冠肺炎大流行给社会各阶层带来了巨大压力。社会孤立、失业、压力、身体疾病、医疗服务负担过重、医疗需求得不到满足以及快速变化的疫情限制对有心理健康问题和药物使用障碍的人产生了特别严重的后果。自疫情开始以来，使用远程健康平台的成瘾治疗（以及整体医疗）已显著扩展到不同的平台和提供系统。特别是，美国报告了转型政策的发展，以便在新冠肺炎大流行期间提供远程医疗。然而，系统性障碍仍然存在，如普遍缺乏互联网接入以及患者和提供者的数字技能不足。综述：总的来说，远程精神病学是治疗药物使用障碍的一种很有前途的方法，但未来还需要更多的随机对照试验来评估可用干预措施的证据基础。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Addiction Reports Psychology-Clinical Psychology

CiteScore

6.60

自引率

4.70%

发文量

期刊介绍： This journal focuses on the prevention, assessment and diagnosis, and treatment of addiction. Designed for physicians and other mental health professionals who need to keep up-to-date with the latest research, Current Addiction Reports offers expert reviews on the most recent and important research in addiction. We accomplish this by appointing leaders in the field to serve as Section Editors in key subject areas and disciplines, such asAlcoholTobaccoStimulants, cannabis, and club drugsBehavioral addictionsGender disparities in addictionComorbid psychiatric disorders and addictionSubstance abuse disorders and HIVSection Editors, in turn, select the most pressing topics as well as experts to evaluate the latest research, report on any controversial discoveries or hypotheses of interest, and ultimately bring readers up-to-date on the topic. Articles represent interdisciplinary endeavors with research from fields such as psychiatry, psychology, pharmacology, epidemiology, and neuroscience.Additionally, an international Editorial Board—representing a range of disciplines within addiction medicine—ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.